Applied Dna Scns (APDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
Operating Expenses | 433 | 147 | -744 | 0 | 597 |
Operating Income | -433 | -147 | 744 | N/A | -597 |
Pre-tax Income | -433 | -147 | 744 | 0 | -597 |
Net Income Continuous | -433 | -147 | 744 | N/A | -597 |
Net Income | $-433 | $-147 | $744 | $N/A | $-597 |
EPS Basic Total Ops | -958.08 | -479.04 | -2,874.25 | N/A | -1,916.17 |
EPS Basic Continuous Ops | -1,095.13 | -678.18 | -2,874.36 | N/A | -1,955.93 |
EPS Diluted Total Ops | -958.08 | -479.04 | -2,874.25 | N/A | -1,916.17 |
EPS Diluted Continuous Ops | -1,095.13 | -678.18 | -2,874.36 | N/A | -1,955.93 |
EBITDA(a) | $-433 | $-147 | $744 | $N/A | $-597 |